 |
|
| |
|
|
|
 |
| |
| PARENTERAL NUTRITION |
| |
| |
|
 |
|
| FreAmine HBC™ |
 |
Stimulates the synthesis of muscle and liver proteins. |
 |
Increases visceral protein levels in stressed patients. |
 |
A more efficient source of nitrogen than standard amino acids. |
|
| |
| FreAmine HBC™, injectable 6.9% amino acid solution, with a high (45%) content of branched-chain amino acids, is an efficient IV protein resource for the hypercatabolic patient. |
| |
| |
| HepatAmine® |
 |
Reverses hepatic encephalopathy. |
 |
Improves survival. |
 |
Provides an optimal level of protein without exacerbating hepatic encephalopathy. |
|
| |
| HepatAmine®, injectable 8% amino acid solution, with a high content of branched-chain amino acids, is low in aromatic amino acids, specifically designed for the hepatic patient. |
| |
| |
| NephrAmine® |
 |
Promotes early recovery of renal function in acute renal failure. |
 |
Improves cellular metabolic balance in patients with acute or chronic renal failure. |
 |
Minimizes/reverses hyperkalemia. |
 |
Reduces the rate of increase of urea nitrogen levels. |
 |
Decreases potassium, magnesium and phosphorus plasma levels. |
|
| |
| NephrAmine®, injectable 5.4% essential amino acid solution, specifically designed for patients with acute or chronic renal failure. |
| |
| |
| ProcalAmine® |
 |
Peripheral administration route. |
 |
Prevents hyperglycemia and hyperinsulinemia. |
 |
Lowe incidence of phlebitis compared to dextrose mixtures. |
 |
Recommended by ASPEN for nutritional support via peripheral route for 14 days or less. |
|
| |
| ProcalAmine®, injectable 3% amino acid and 3% glycerol solution with electrolytes, nutrition support via peripheral route for slightly catabolic patients who require short-term parenteral nutrition. |
| |
| |
| TrophAmine® |
 |
Normalizes plasma amino acid concentrations. |
 |
Promotes weight gain. |
 |
Improves nitrogen balance. |
 |
Reduces the incidence of cholestasis. |
|
| |
| TrophAmine®, injectable 6% and 10% amino acid solution, is a parenteral AA solution that normalizes plasma concentration of amino acids in healthy infants and stimulates growth in neonatal and pediatric patients. |
| |
| |
| PRESENTATIONS |
| |
| STANDARD AMINO ACIDS |
| S9040-SS |
FreAmine III® (3% amino acids with electrolytes) 1000 ml, 6/case. |
| S9030-SS |
FreAmine III® (8.5% amino acids) 1000 ml, 6/case. |
| S9031-SS |
FreAmine III® (8.5% amino acids) 500 ml, 12/case. |
| S9010-SS |
FreAmine III® (10% amino acids) 1000 ml, 6/case. |
| S9011-SS |
FreAmine III® (10% amino acids) 500 ml, 12/case. |
|
| |
| SPECIALIZED AMINO ACIDS |
| S9350-58 SS |
FreAmine HBC™ (6.9% amino acids) 750 ml in 1000 ml bottle, 6/case. |
| S9371-SS |
HepatAmine® (8% amino acids) 500 ml, 6/case. |
| S9092-SS |
NephrAmine® (essential amino acids) 250 ml, 12/case. |
| S9050 |
ProcalAmine® (3% amino acids and 3% glycerol with electrolytes) 1000 ml, 6/case. |
| S9361-SS |
TrophAmine® (6% amino acids) 500 ml, 12/case. |
| S9341-SS |
TrophAmine® (10% amino acids) 500 ml, 6/case. |
|
| |
| |
| |
|
|
|
|
| |
| |
|
| |
Home | Company | Products | Shopping Cart | Catalog | Contact us | Term of use | Privacy Policy |
| © 2012, Victus. All Rights Reserved. |